This is a preview of subscription content, log in via an institution to check access.
Notes
The Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin
Reference
Cohen AT, et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. New England Journal of Medicine 368: 513-23, No. 6, 7 Feb 2013. Available from: URL: http://dx.doi.org/10.1056/NEJMoa1111096
Rights and permissions
About this article
Cite this article
Rivaroxaban of no net clinical benefit in critically ill patients. Reactions Weekly 1441, 3 (2013). https://doi.org/10.1007/s40278-013-1601-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-1601-8